David Ermert
11 – 18 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2017
-
Mark
Factor H–IgG chimeric proteins as a therapeutic approach against the gram-positive bacterial pathogen Streptococcus pyogenes
(
- Contribution to journal › Article
-
Mark
PRELP enhances host innate immunity against the respiratory tract pathogen moraxella catarrhalis
(
- Contribution to journal › Article
- 2016
-
Mark
Moraxella catarrhalis Evades Host Innate Immunity via Targeting Cartilage Oligomeric Matrix Protein.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend.
(
- Contribution to journal › Scientific review
-
Mark
FACIN, a double-edged sword of the emerging periodontal pathogen filifactor alocis : A metabolic enzyme moonlighting as a complement inhibitor
(
- Contribution to journal › Article
-
Mark
Moonlighting of Helicobacter pylori catalase protects against complement-mediated killing by utilising the host molecule vitronectin
(
- Contribution to journal › Article
- 2015
-
Mark
Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.
(
- Contribution to journal › Article
- 2013
-
Mark
Binding of complement inhibitor C4b-binding protein to a highly virulent S. pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »